Marie-eve Gagne-Laliberte

2705 Boulevard Laurier
Quebec, QC G1V4G2, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection.

A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection.

Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: April 20, 2022

Modulation of Antigen Display on PapMV Nanoparticles Influences Its Immunogenicity.

Modulation of Antigen Display on PapMV Nanoparticles Influences Its Immunogenicity.

Journal: Vaccines
Published: December 10, 2020

A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18-50 Years of Age.

A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18-50 Years of Age.

Journal: Vaccines
Published: May 20, 2020

Increased Immunogenicity of Full-Length Protein Antigens through Sortase-Mediated Coupling on the PapMV Vaccine Platform.

Increased Immunogenicity of Full-Length Protein Antigens through Sortase-Mediated Coupling on the PapMV Vaccine Platform.

Journal: Vaccines
Published: May 13, 2019

The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses.

The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses.

Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: May 15, 2018

Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7/8 agonist.

Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7/8 agonist.

Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: July 18, 2017

A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling.

A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling.

Journal: Journal of nanobiotechnology
Published: October 05, 2016

PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine.

PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine.

Journal: Journal of nanobiotechnology
Published: March 04, 2014
Showing 1-8 of 8

Last Updated: 09/26/2026